Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Innocan Pharma Corp
(CSE:
INNO
)
0.2500
+0.0100 (+4.17%)
Official Closing Price
Updated: 1:49 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
621,134
Open
0.2500
Bid (Size)
0.2450 (2,000)
Ask (Size)
0.2500 (15,000)
Prev. Close
0.2400
Today's Range
0.2450 - 0.2600
52wk Range
0.1850 - 0.4100
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
May 28, 2024
Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.
Via
Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration...
Via
Benzinga
Exposures
Product Safety
Performance
YTD
-19.35%
-19.35%
1 Month
+4.17%
+4.17%
3 Month
-10.71%
-10.71%
6 Month
-19.35%
-19.35%
1 Year
-32.43%
-32.43%
More News
Read More
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
April 02, 2024
Via
Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
Via
Benzinga
Exposures
Product Safety
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
October 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
September 21, 2023
Via
Benzinga
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
August 28, 2023
Via
Benzinga
Industry Update: Innocan Pharma Accelerates Commercialization in Europe Following Impressive Revenue Growth
May 03, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Innovative Delivery Systems Create Unique Opportunities in the Billion-Dollar Pain Market (CSE: INNO)
November 14, 2022
Via
AB Newswire
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma Provides an Operational Update
September 21, 2022
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment
September 09, 2022
Via
Newsfile
Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
September 06, 2022
Via
Newsfile
Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
September 03, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021
August 27, 2021
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University
August 18, 2021
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada
August 11, 2021
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)
August 03, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss
July 28, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee
July 14, 2021
Via
Newsfile
Topics
Artificial Intelligence
Supply Chain
Exposures
Artificial Intelligence
COVID-19
Supply Chain
Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms
July 09, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland
July 01, 2021
Via
Newsfile
Topics
Economy
Supply Chain
Exposures
COVID-19
Economy
Supply Chain
Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study
June 24, 2021
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution
June 16, 2021
Via
Newsfile
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment
June 14, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
